New research shows a second COVID-19 vaccine dose may not be necessary in individuals previously infected with SARS-CoV-2.
The dose finding study will assess the safety, reactogenicity and immunogenicity of the investigational COVID-19 vaccine in 720 participants.
EPR’s Hannah Balfour discusses how COVID-19 has impacted the pharma industry with regard to cancer clinical trial and treatment disruptions.
Research shows at least a fifth of the US population are resistant to COVID-19 vaccination, potentially due to disinformation.
In vitro neutralisation assays show REGEN-COV and AZD7442 are effective against new SARS-CoV-2 variants, while other antibodies were not.
Results from in vitro neutralisation studies have shown that Moderna's COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Workers critical to the UK COVID-19 vaccine supply chain will be offered inoculations against the novel coronavirus.